| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |